Aclaris Therapeutics, Inc. Insider Trading for April 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aclaris Therapeutics, Inc. for April 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2018 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | A | 17.73 | 16,000 | 283,680 | 16,000 | |
| Apr 09 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | P | 16.59 | 1,250 | 20,738 | 155,615 | 154.4 K to 155.6 K (+0.81 %) |
| Apr 09 2018 | ACRS | Aclaris Therapeuti ... | Tullman Stephen A. | Director | Buy | P | 16.54 | 26,700 | 441,618 | 157,507 | 130.8 K to 157.5 K (+20.41 %) |
| Apr 09 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | S | 16.52 | 2,300 | 37,996 | 7,682 | 5.4 K to 7.7 K (+42.74 %) |
| Apr 09 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | P | 16.75 | 10,000 | 167,500 | 897,184 | 887.2 K to 897.2 K (+1.13 %) |